Daily Global Pathogen Briefing
Daily Update | August 17, 2026
Executive Summary
● DR Congo’s Ebola outbreak is on track to be the largest in history: cases have surpassed 4,000 and deaths are approaching/exceeding 2,000 (~40% case fatality rate), with WHO and Africa CDC warning the response is being outpaced and no “magical solution” in sight.
● US measles total has topped 2,500 cases in 2026, concentrated in Pennsylvania and Ohio; an expert panel is reviewing whether the US has lost its measles elimination status after 26 years.
● H5N1/H9N2 avian flu keeps widening its footprint: Australia recorded its first-ever wild-bird H5N1 detection, Cambodia confirmed a human case in an infant, China logged 4 more H9N2 human cases (20 in six months), and US dairy-cattle spillover continues (Idaho, Utah).
● Mpox clade Ib is gaining ground outside Africa: Berlin is seeing a rapid rise in locally-acquired (non-travel) clade Ib cases, and New Hampshire, Missouri, and New York City have each logged clade I clusters, while DRC deaths have passed 600.
Pathogen-by-Pathogen Briefing
1. SARS-CoV-2 / COVID-19
Status: No acute surveillance data (variant tracking, case/hospitalization trends) was retrievable this cycle — data gap. Available coverage this cycle skewed toward long-term outcomes: Long COVID symptoms persist into a second year for most affected, with post-exertional malaise in 36% of persistent cases; night-shift workers show 88% higher Long COVID risk; severe COVID can accelerate arterial plaque formation with elevated cardiac/stroke risk for about a year after infection; and up to 5% of hospital healthcare workers report Long COVID.
● A retrospective analysis credited COVID vaccination in one Washington county with preventing over 4,000 deaths and averting 20,000+ severe outcomes since rollout.
Severity: Moderate
Trend: Data gap on current case trend; no new variant-of-concern signal identified
Why it matters now: The Long COVID evidence keeps accumulating even without an acute surge — a reminder that prevention (masking in high-risk settings, staying current on boosters, cleaner indoor air) still pays off against the long tail of this virus, not just the acute illness.
2. Measles
Status: US case total has topped 2,500 in 2026 (2,371 confirmed as of the last full count, plus 101 more new cases in the latest update), with most new cases concentrated in Pennsylvania and Ohio.
● An expert panel is actively reviewing whether the US has lost its measles elimination status, 26 years after it was first declared in 2000.
● A federal executive order addressing the MMR vaccine schedule/structure is also in play, layering policy uncertainty onto the outbreak.
Severity: High
Trend: Increasing
Why it matters now: Losing US elimination status would be a historic, largely preventable setback — and it tracks directly with the vaccination coverage gaps driving the PA/OH case growth.
3. Diphtheria
Status: WHO’s diphtheria fact sheet (updated July 15, 2026) confirms outbreaks are “occurring with increasing frequency” as a direct consequence of under-vaccination, with recent Disease Outbreak News notifications for Guinea and Nigeria.
● Globally, only 85% of infants received the recommended 3-dose primary series in 2025, leaving roughly 20 million children under- or unvaccinated; only 83 countries have all three WHO-recommended booster doses in their national programs, and 42 have none at all.
Severity: Moderate
Trend: Slowly worsening, driven by coverage gaps
Why it matters now: Diphtheria resurgences concentrate in conflict- and disaster-affected regions where routine immunization has broken down — it’s an early-warning bellwether for other vaccine-preventable diseases in the same populations.
4. Avian Flu (H5N1 / H9N2)
Status: Australia recorded its first-ever H5N1 detection in wild birds, ending its status as one of the last H5N1-free continents.
● Cambodia confirmed a human H5N1 case in an infant.
● China reported 4 new human H9N2 cases (including a one-year-old girl), bringing the total to 20 detections over the past six months.
● In the US, Utah reported H5N1 in both egg-laying poultry and cattle, Idaho logged further dairy-cattle infections (54 cases year-to-date), and roughly 72 H5N1 detections in dairy cows have been recorded nationally this year.
Severity: Moderate-High
Trend: Expanding geographically
Why it matters now: A first detection in Australia closes off one of the last unaffected continents, and continued mammalian (dairy cattle) spillover in the US keeps pandemic-potential concerns elevated even without evidence of sustained human-to-human transmission.
5. Pertussis (Whooping Cough)
Status: Preliminary 2026 US data show fewer cases than the same period in 2025, continuing a decline from a November 2024 peak that was more than 6 times 2023’s case count and exceeded pre-pandemic 2019 levels.
● 2025 case reports stayed elevated relative to early-pandemic years before trending down after the peak.
● Infants under one year remain at the greatest risk for severe illness and death; antibiotic-resistant B. pertussis remains rare in the US but is increasingly reported in Asia, Australia, Europe, and South America.
Severity: Moderate
Trend: Declining from the 2024 peak, but still above pre-pandemic baseline
Why it matters now: CDC notes much of the true disease burden likely goes unrecognized and unreported — maternal Tdap vaccination remains the key lever for protecting infants during the highest-risk window.
6. Ebola
Status: DRC outbreak: genomic sequencing shows the virus was circulating from mid-February, though it wasn’t officially declared until May 17 (earlier cases were likely misdiagnosed as malaria or typhoid).
● Cases have surpassed 4,000 and deaths are approaching/exceeding 2,000 (roughly 40% case fatality rate), with an average of 75–80 new cases per day over the three months since declaration.
● WHO and outside trackers describe it as on track to be the largest Ebola outbreak in history, and already the second-deadliest on record for DRC; 60–70% of deaths are still occurring in the community rather than in care facilities.
● Two vaccine candidates have entered phase 1 trials, and existing stockpiled vaccines appear to generate antibody responses against the outbreak strain; the Africa CDC chief has said there is “no magical solution” as the response struggles to keep pace.
Severity: High
Trend: Worsening / accelerating
Why it matters now: This is shaping up as a major test of global outbreak response capacity — the trajectory toward “largest in history,” combined with a high share of community deaths, points to gaps in case-finding and safe burial practices that need urgent reinforcement.
7. RSV
Status: No acute outbreak signal this cycle (Northern Hemisphere off-season baseline). Coverage focused on immunization performance ahead of the fall/winter season.
● Maternal RSV vaccination is linked to roughly a 70% reduction in infant hospitalizations; surveyed parents and pregnant patients generally prefer the maternal vaccine over the infant monoclonal antibody shot, though both are described as highly effective.
● A Mayo Clinic study found asthma, chronic kidney disease, and similar conditions nearly double severe RSV risk in adults under 50 — a group not yet broadly recommended for vaccination.
● Newborn RSV immunization was also linked to a 36% lower risk of invasive pneumococcal disease.
Severity: Low-Moderate
Trend: Stable / seasonal baseline
Why it matters now: The immunization evidence base keeps strengthening right before the season that matters most — a good moment to get eligible patients (pregnant women, infants, older/high-risk adults) scheduled before RSV activity picks up.
8. Influenza A
Status: Data gap this cycle: CIDRAP’s influenza feed returned mostly retrospective items (2024–25 vaccine effectiveness, oseltamivir’s benefit in reducing ICU admission/length of stay for children, and a finding that COVID patients co-infected with flu are 4 times more likely to need mechanical ventilation) rather than current subtype-specific surveillance.
● No confirmed current Influenza A activity level or dominant-subtype data was retrieved this cycle.
Severity: Data gap
Trend: Data gap
Why it matters now: The Southern Hemisphere winter flu season is underway; confirming the current subtype mix and severity via WHO FluNet or CDC FluView should be a priority for the next cycle.
9. Influenza B
Status: Data gap this cycle: no Influenza-B-specific surveillance data was retrieved from the sources available this run.
Severity: Data gap
Trend: Data gap
Why it matters now: Influenza B co-circulation affects vaccine strain matching for the coming season; will confirm status directly next cycle.
Other Outbreaks of Interest
Mpox (Clade Ib / Clade I)
Status: Berlin is seeing a rapid rise in locally-acquired (non-travel) clade Ib cases, marking a shift from earlier travel-linked introductions.
● New Hampshire: one infected person exposed 17 others across two group homes. Missouri and New York City have each logged clade I cases as well.
● DRC’s expanding outbreak has passed 600 deaths, and the Republic of Congo has reported its first cases.
● European regulators found tecovirimat (Tpoxx) no better than placebo for healing lesions, relieving pain, or clearing virus — a setback for the leading antiviral option.
● New transmission data suggest nonsexual-contact spread is uncommon, but true infections may outnumber diagnosed cases by roughly 33 to 1, potentially reflecting undetected asymptomatic spread; CDC’s test may also be unreliable for some clade I substrains. Dose-sparing Jynneos vaccination continues to show good effectiveness.
Severity: High
Trend: Increasing, with new geographic footholds
Why it matters now: Clade Ib’s foothold in Berlin plus repeated US clusters suggest travel-history-based case-finding alone is no longer sufficient to contain spread — surveillance and testing reliability need to catch up.
Dengue
Status: US cases rose 359% in 2024 amid a global surge; most US infections were travel-associated, but competent mosquito vectors are now present across much of the country.
● Sri Lanka has reported over 80,000 cases this year.
● Research links rising temperatures to expanding dengue transmission in low- and middle-income countries via increased mosquito-bite rates and longer transmission seasons.
● The Butantan vaccine shows ~81% efficacy against severe disease (5+ years) and 65% against symptomatic disease, but a vaccination campaign in Brazil was halted; separate research flags a Guillain-Barré syndrome risk from dengue comparable to influenza and Campylobacter.
Severity: Moderate-High
Trend: Increasing
Why it matters now: Climate-driven range expansion plus a paused vaccine campaign in Brazil complicate control just as case counts are climbing in multiple regions.
Cholera
Status: Sudan’s 18-month outbreak has ended, with a final toll over 100,000 cases and an estimated 2,408 deaths.
● DR Congo: over 58,000 cases across 9 months with roughly 1,700 deaths; Chad and the Republic of Congo are both seeing sharp increases in cases.
● Mozambique has restarted preventive vaccination campaigns halted since a 2022 global vaccine-supply shortage; a genetically modified live-attenuated vaccine candidate has entered phase 1 trials.
● Global case counts reportedly declined about 27% month-over-month in the most recent comparison cited, even as five African countries remain in acute, high-mortality outbreak status.
Severity: High (regional) / Moderate (global trend)
Trend: Mixed — improving globally, still acute in several African countries
Why it matters now: Cholera remains a stark marker of water and sanitation infrastructure gaps, usually compounded by conflict or displacement — the regional picture (DRC, Chad, Republic of Congo) is far worse than the encouraging global average suggests.
Foodborne Illness (Cyclospora / multiple recalls)
Status: A large Cyclospora outbreak tied to recalled iceberg lettuce has effectively resolved as the product’s best-by dates have now passed, per FDA.
● CIDRAP also flagged a broader wave of concurrent US foodborne-illness recalls this cycle, beyond the Cyclospora event.
Severity: Moderate
Trend: Resolving (this event), but part of a broader multi-outbreak pattern
Why it matters now: Produce-linked contamination can keep moving through the supply chain quietly even after a recall is announced — worth a follow-up check that no secondary cases are still surfacing.
Watchlist (Pathogens to Monitor Closely)
★ SARS-CoV-2 — watch for new variant signals and fill this cycle’s case/hospitalization data gap.
★ Measles — whether the US formally loses its elimination status; continued PA/OH growth.
★ Ebola (DRC) — on a trajectory toward the largest outbreak in history; response capacity is reportedly being outpaced.
★ Mpox clade Ib — Berlin and repeated US clusters signal spread beyond travel-linked case-finding.
★ Avian flu (H5N1/H9N2) — Australia’s first detection and continued mammalian spillover in the US.
★ Cholera — acute, high-mortality outbreaks continuing in DRC, Chad, and Republic of Congo despite a better global average.
References
CIDRAP — homepage news roundup
CIDRAP — “WHO: Ebola outbreak began in February, deaths near 2,000”
CIDRAP — Avian influenza / bird flu topic page
WHO — Disease Outbreak News portal (no results returned this cycle)
Watch Items for Next Briefing
1. Confirm current Influenza A and B subtype circulation and severity via WHO FluNet or CDC FluView (data gap this cycle).
2. Track updated DRC Ebola case/death counts to confirm (or revise) the “largest outbreak in history” trajectory.
3. Watch for a formal CDC/expert-panel determination on US measles elimination status.
4. Monitor for further H5N1/H9N2 human cases beyond Cambodia and China, and any human cases linked to the Australian wild-bird detection.
5. Fill the COVID-19 data gap: current variant landscape, wastewater trend, and hospitalization data.
6. Track mpox clade Ib case growth in Berlin and watch for further European spread.
7. Compare Chad/Republic of Congo cholera trends against the reported 27% global monthly decline.
A gentle reminder as always: a little kindness, a mask in crowded indoor spaces, staying current on your boosters, and pushing for cleaner indoor air all go a long way toward preventing Long COVID and easing the burden of the respiratory illnesses making the rounds this season.
Take care,
Joe